Moderate to Severe Atopic Dermatitis Research Trial (77 Weeks)

For condition: Atopic Dermatitis
For condition: Eczema – Atopic Dermatitis

Moderate to Severe Atopic Dermatitis Research Trial (77 Weeks)

Study Summary

Who Can Participate?

Adults 18 to 75 years of age (inclusive) with atopic dermatitis (AD), may be eligible to participate in this clinical research trial (sponsored by Kymera Therapeutics, Inc.).

Inclusion Criteria: 

  • Chronic atopic dermatitis that has been present for at least 3 years
  • Moderate to severe AD
  • At least 10% body surface area (BSA) of AD involvement (i.e. equal to 10 palm prints)
  • 6-month history of either an inadequate response to, or contraindication to, topical medications
  • Has been using an emollient twice daily for at least 1 week, and should continue using that same emollient throughout the study

Participant Info:

  • No cost to participate or receive study medication
  • Regular visits with study doctors who are familiar with treating AD
  • Will receive investigational oral medication (active study drug) or placebo
  • Reimbursement for time and travel to the clinic may be provided

How Long Will The Study Last?

Participation will last about 77 weeks and involve about 24 visits to the study research site.

Click here to Register

For more information about this trial, please visit ClinicalTrials.gov

Ready to Find a Trial?

Start your journey here.
Find a Trial

Can’t Find a Trial Near You?

Complete a general registration to let us know who you are and what you’re interested in. We can keep your information on file and contact you when there is a trial that may be suitable for you.
General Registration

Privacy Policy

Last Revised: July 2024

I agree to the Privacy PolicyI do not agree

Registration

Enrolling:

Clinic:

Doctor:

Please fill in your contact details:

Find a Trial